Document:

EX-10.1

 Exhibit 10.1 

EMPLOYMENT AGREEMENT 

This EMPLOYMENT AGREEMENT (the “Agreement”), dated as of this 1st day of January, 2015 (the “Effective
Date”) is made by and between Corrections Corporation of America, a Maryland corporation (the “REIT”), CCA of Tennessee, LLC, a Tennessee limited liability company (“Employer” and, together with the REIT,
the “Company”), and                     , a resident of
                     (the “Executive”). 

W I T N E S S E T H: 

WHEREAS, the Executive is currently employed by the Company as its
                    ; 

WHEREAS, the Employment Agreement between the Company and the Executive, dated as of
                    , 20    , expired on December 31, 2014; and 

WHEREAS, effective as of the Effective Date, the Company and the Executive desire to enter into this Agreement to set forth the terms
and conditions of the Executive’s continued employment with the Company. 
 NOW, THEREFORE, for and in consideration of the
foregoing recitals, the mutual promises and covenants set forth below and other good and valuable consideration, receipt of which is hereby acknowledged, the Company and the Executive do hereby agree as follows: 

1. Employment. Effective as of the Effective Date, the Executive shall serve as
                     of the Company. The Executive shall perform such duties as are customarily associated with the office of
                     and shall report to
                    . The Executive’s principal base of operations for the performance of his duties and responsibilities under this
Agreement shall be the offices of the Company located in Nashville, Tennessee. At the Company’s request, Executive shall serve the Company and/or its subsidiaries and affiliates in such other capacities in addition to the foregoing as the
Company shall designate, provided that such additional capacities are consistent with Executive’s position as                     . In
the event that Executive serves in any one or more of such additional capacities, Executive’s compensation shall not be increased on account of such additional service beyond that specified in this Agreement. 

2. Term. Subject to the provisions of termination as hereinafter provided, the initial term of the Executive’s employment under
this Agreement shall begin on the Effective Date and shall terminate on December 31, 2015 (the “Initial Term”). Unless the Company notifies the Executive that his employment under this Agreement will not be extended or the
Executive notifies the Company that he is not willing to extend his employment, the term of his employment under this Agreement shall automatically be extended for a series of two (2) additional one (1) year periods on the same terms and
conditions as set forth herein (each, a “Renewal Term”). The Initial Term and any Renewal Term(s) are sometimes referred to collectively herein as the “Term.” 

3. Notice of Non-Renewal. The Company or the Executive may elect not to extend the Executive’s employment under this Agreement by
notifying the other party in writing not less than sixty (60) days prior to the expiration of the Initial Term or any Renewal Term. For the purposes of this Agreement, the election by the Company not to extend the Executive’s employment
hereunder for any renewal term, shall be deemed a termination of the Executive’s employment without “Cause,” as hereinafter defined. 

 4. Compensation. 

4.1 Base Salary. During the Term, the Company shall pay the Executive an annual salary (“Base Salary”) of
                     dollars ($            ) per annum, which shall be
payable to the Executive hereunder in accordance with the Company’s normal payroll practices, but in no event less often than bi-weekly. The Executive’s compensation will be reviewed annually by the Board of Directors of the REIT (the
“Board”), or the Compensation Committee of the Board, and after taking into consideration both the performance of the Company and the personal performance of the Executive, the Board, or the Compensation Committee of the Board, in
its sole discretion, may increase the Executive’s compensation to any amount it may deem appropriate. 
 4.2 Bonus. In addition
to the Base Salary, the Executive shall be eligible to earn, for each fiscal year of the Company ending during the Employment Period, an annual cash performance bonus (an “Annual Bonus”) under the Company’s bonus plan or
program applicable to senior executives. The actual amount of the Annual Bonus shall be determined on the basis of the attainment of financial performance metrics and/or individual performance objectives, in each case as established and approved by
the Board or the Compensation Committee of the Board in its sole discretion. This Annual Bonus, if any, shall be pro-rated for any partial year of employment and paid to the Executive between January 1 and March 15 of the year following
the year in which the services which gave rise to the Annual Bonus were performed; provided, however, that if the Company is unable to determine the amount of such Annual Bonus prior to such date, then such Annual Bonus shall be paid no later
than December 31 of such year. The Board or the Compensation Committee of the Board, may, in its sole discretion, review, revise and amend the terms of the cash compensation incentive or similar plan(s) referenced above, if any, at any time in
any manner it may deem appropriate; provided, however, that any amendment to the plan(s) shall not, without the Executive’s consent, affect the Executive’s right to participate in such amended plan or plans or change the time or
form of payment provided thereunder, except to the extent necessary to comply with applicable law. 
 4.3 Benefits. During the Term,
the Executive shall be entitled to four (4) weeks of paid vacation annually. In addition, during the Term, the Executive shall be eligible to participate in all compensation or employee benefit plans or programs maintained by the Company for
the benefit of its salaried employees or senior executives from time to time. The Executive will be eligible to participate to the extent permissible under the terms and provisions of such plans or programs in accordance with their respective
provisions. These plans and programs may include group hospitalization, health, dental care, life or other insurance, tax qualified pension, savings, thrift and profit sharing plans, termination pay programs, sick leave plans, travel or accident
insurance, disability insurance, and contingent compensation plans including unit purchase programs and unit option plans. Nothing in this Agreement shall require the Company to maintain or continue, or preclude the Company from amending or
terminating, any employee benefit plans or programs. In addition, during the Term, the Company shall pay, or reimburse Executive for, all membership fees and related costs in connection with Executive’s membership in professional and civic
organizations which are approved in advance by the Company. 
 4.4 Expenses Incurred in Performance of Duties. The Company shall
promptly reimburse the Executive for all reasonable travel and other business expenses incurred by the Executive in the performance of his duties under this Agreement upon evidence of receipt and in accordance with Company policies. 

4.5 Withholdings. All compensation payable hereunder shall be subject to withholding for federal income taxes, FICA and all other
applicable federal, state and local withholding requirements. 

  
 2 

 5. Termination of Agreement. 

5.1 General. During the Term of this Agreement, the Company may, at any time and in its sole discretion, terminate this Agreement with
or without Cause (as hereinafter defined) or in connection with a Change in Control (as hereinafter defined), effective as of the date of provision of written notice to the Executive thereof. The Executive shall be entitled to resign his employment
with the Company at any time during the Term of this Agreement with Good Reason (as defined below) or without Good Reason. 
 5.2
Definition of Cause. For purposes of this Agreement, “Cause” shall mean: (i) the death of the Executive; (ii) the permanent disability of the Executive, which shall be defined as the inability of the Executive, as a
result of physical or mental illness or incapacity, to substantially perform his duties pursuant to this Agreement for a period of one hundred eighty (180) days during any twelve (12) month period; (iii) the Executive’s
conviction of a felony or of a crime involving dishonesty or moral turpitude, including, without limitation, any act or crime involving misappropriation or embezzlement of Company assets or funds; (iv) willful or material wrongdoing by the
Executive, including, but not limited to, acts of dishonesty or fraud, which could be expected to have a materially adverse effect, monetarily or otherwise, on the Company or its subsidiaries or affiliates, as determined by the Company and the
Board; (v) material breach by the Executive of this Agreement or of his fiduciary duty to the Company or its stockholders; or (vi) the Executive’s intentional violation of any applicable local, state or federal law or regulation
affecting the Company in any material respect, as determined by the Company and the Board. Notwithstanding the foregoing, to the extent that any of the events, actions or breaches set forth above are able to be remedied or cured by the Executive,
Cause shall not be deemed to exist (and thus the Company may not terminate the Executive for Cause hereunder) unless the Executive fails to remedy or cure such event, action or breach within twenty (20) days after being given written notice by
the Company of such event, action or breach. 
 5.3 Definition of Good Reason. For purposes of this Agreement, “Good
Reason” shall mean: (i) a material reduction in the duties, powers or authority of the Executive as an officer or employee of the Company or (ii) the relocation of the Company’s headquarters to a location more than thirty
(30) miles outside of the Nashville, Tennessee metropolitan area, in either case, without the Executive’s consent. A termination shall be due to Good Reason only if (A) the Executive notifies the Company of the existence of the
condition that otherwise constitutes Good Reason within thirty (30) days of the initial existence of the condition, (B) the Company fails to remedy the condition within thirty (30) days following it’s receipt of Executive’s
notice of the condition constituting Good Reason (the “Cure Period”) and (C) if the Company fails to remedy the condition constituting Good Reason during the Cure Period, the Executive terminates employment with the Company due
to the condition within thirty (30) days of the expiration of the Cure Period. 
 5.4 Effect of Termination Without Cause or for
Good Reason. If the Executive’s employment with the Company is terminated without Cause or for Good Reason (and is not a Change in Control Termination, as defined below), in either case, subject to Section 5.7 and the Executive’s
continued compliance with Section 6.1 and Section 6.2 hereof, the Company shall pay to the Executive an amount in cash equal to the Executive’s Base Salary, based upon the annual rate payable as of the date of termination, without any
cost of living adjustments (the “Severance Amount”), which shall be paid by the Company to Executive in regular installments in accordance with the Company’s normal payroll policies then in effect, for a period of one
(1) year following the Executive’s termination of employment (the “Severance Period”), which payments will commence with the first payroll period occurring after the expiration of the Severance Delay Period (the
“Initial Payment”) and shall continue for the remainder of the Severance Period. The Initial Payment shall include payment for any payroll periods which occur during the Severance Delay Period. For purposes of this Agreement, the
“Severance Delay Period” shall mean the period beginning on the date of the Executive’s termination of employment and ending on the thirtieth (30th) day thereafter. 

  
 3 

 5.5 Effect of a Change in Control Termination. If the Executive’s employment with the
Company is terminated due to a Change in Control Termination, subject to Section 5.7 and the Executive’s continued compliance with Section 6.1 and Section 6.2 hereof, the Company shall (i) pay to the Executive a lump-sum
cash payment equal to 2.99 times the Executive’s Base Salary, based upon the annual rate payable as of the date of termination, without any cost of living adjustments, which payment shall be made within ten (10) days following the
expiration of the Severance Delay Period and (ii) continue to provide hospitalization, health, dental care, and life and other insurance benefits to the Executive for a period beginning on the date of the Executive’s termination and ending
on the one (1) year anniversary of such termination or, if earlier, the date on which the Executive becomes eligible to receive comparable benefits from any other employer or the date on which such coverage terminates under Section 4980B
of the Code (as defined below) (in any case, the “Change in Control Severance Period”) on the same terms and conditions existing immediately prior to termination, with the costs of such benefits (including the Company’s portion
of any premiums) paid by the Company on the Executive’s behalf included in the Executive’s gross income to the extent required by applicable law; provided, that the Executive shall continue to pay the same amount towards the cost of
such benefits as paid immediately prior to the date of termination and shall comply with all applicable election and eligibility requirements; provided further, that if any plan pursuant to which such benefits are provided is not, or ceases
to be, exempt from the application of Section 409A of the Code or the Company cannot provide the benefits without violating applicable law, then the Company shall instead pay to the Executive a lump-sum amount equal to the remaining costs of
such benefits that would be paid by the Company through the Change in Control Severance Period (or remaining portion thereof). For purposes of this Agreement, (x) a “Change in Control Termination” shall mean: (i) the
Executive’s employment with the Company is terminated without Cause within one-hundred eighty (180) days following a Change in Control, or (ii) the Executive resigns his employment with the Company for Good Reason within one-hundred
eighty (180) days following a Change in Control; and (y) a “Change in Control” shall mean a “change in the ownership of the Company,” a “change in the effective control of the Company,” or a
“change in the ownership of a substantial portion of the assets of the Company” as such terms are defined in Section 1.409A-3(i)(5) of the Treasury Regulations. 

5.6 Other Terminations. If the Executive’s employment terminates for any reason not described in Sections 5.4 or 5.5 above
(including, without limitation, due to the Executive resigning his employment with the Company without Good Reason, due to a termination of the Executive’s employment by the Company for Cause): (i) the Company shall pay the Executive his
Base Salary earned through the date of termination of the Executive’s employment with the Company as the result of his resignation, which payment shall be made upon the regular payroll period occurring immediately following the Executive’s
termination of employment; and (ii) the Company shall not have any further obligations to the Executive under this Agreement except those required to be provided by law or under the terms of any other agreement between the Company and the
Executive. 
 5.7 Conditions. Any payments or benefits made or provided pursuant to Sections 5.4 and 5.5 of this Agreement shall be
available if and only if (i) the Executive has executed and delivered to the Company the General Release substantially in form and substance as set forth in Exhibit A attached hereto, the General Release has become effective, the
Executive has not revoked the General Release and all applicable revocation periods with respect to the General Release have expired, in all instances, prior to the expiration of the Severance Delay Period and (ii) the Executive has not
breached the provisions of the General Release or breached the provisions of Sections 6.1 or Section 6.2 hereof. In no event shall cash severance payments received pursuant to Section 5.4 or 5.5 hereof be reduced as a result of the receipt
by the Executive of compensation or benefits from a subsequent employer during the period during which severance payments are being made under Section 5.4 or 5.5 above, as applicable. 

  
 4 

 5.8 Section 409A and Other Tax Provisions. 

(i) It is intended that (1) each installment of the payments provided under this Agreement is a separate “payment” for purposes
of Section 409A of the United States Internal Revenue Code of 1986 (the “Code”) and (2) the payments satisfy, to the greatest extent possible, the exemptions from the application of Section 409A of the Code, including
those provided under Treasury Regulations 1.409A-1(b)(4), 1.409A-1(b)(9)(iii), and 1.409A-1(b)(9)(v). Notwithstanding anything to the contrary in this Agreement, if the Company determines in accordance with its “specified employee”
procedures (i) that on the date Executive’s employment with the Company terminates or at such other time that the Company determines to be relevant, the Executive is a “specified employee” (as such term is defined under Treasury
Regulation 1.409A-1(i)(1)) of the Company and (ii) that any payments to be provided to the Executive pursuant to this Agreement are or may become subject to the additional tax under Section 409A(a)(1)(B) of the Code or any other taxes or
penalties imposed under Section 409A of the Code (“Section 409A Taxes”) if provided at the time otherwise required under this Agreement then (A) such payments shall be delayed until the date that is six months after the
date of Executive’s “separation from service” (as such term is defined under Treasury Regulation 1.409A-1(h)) with the Company, or, if earlier, the Executive’s death (the “Payment Delay Period”) and (B) such
payments shall be increased by an amount equal to interest on such payments for the Payment Delay Period at a rate equal to the prime rate in effect as of the date the payment was first due (for this purpose, the prime rate will be based on the rate
published from time to time in The Wall Street Journal). Any payments delayed pursuant to this Section 5.8(i) shall be made in a lump sum on the first day of the seventh month following the Executive’s “separation from service”
(as such term is defined under Treasury Regulation 1.409A-1(h)), or, if earlier, the Executive’s death. It is intended that this Agreement shall comply with or be exempt from the provisions of Section 409A of the Code and the Treasury
Regulations relating thereto so as not to subject Executive to the payment of additional taxes and interest under Section 409A of the Code. In furtherance of this intent, this Agreement shall be interpreted, operated, and administered in a
manner consistent with these intentions. 
 (ii) Notwithstanding any other provision of this Agreement to the contrary, a termination of
employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of “deferred compensation” (as such term is defined in Section 409A of the Code and the Treasury Regulations
promulgated thereunder) upon or following a termination of employment unless such termination is also a “separation from service” from the Company within the meaning of Section 409A of the Code and Section 1.409A-1(h) of the
Treasury Regulations and, for purposes of any such provision of this Agreement, references to a “separation,” “termination,” “termination of employment,” “termination of the Executive’s employment,”
“date of termination” or like terms shall mean the Executive’s “separation from service.” 
 (iii) Notwithstanding
any other provision of this Agreement to the contrary, in no event shall any payment under this Agreement that constitutes “deferred compensation” for purposes of Section 409A of the Code and the Treasury Regulations promulgated
thereunder be subject to offset by any other amount unless otherwise permitted by Section 409A of the Code. 
 (iv) For the avoidance
of doubt, any payment due under this Agreement within a period following Executive’s termination of employment or other event, shall be made on a date during such period as determined by the Company in its sole discretion. 

  
 5 

 (v) To the extent that any reimbursement, fringe benefit or other, similar plan or arrangement in
which Executive participates during the term of Executive’s employment under this Agreement or thereafter (including reimbursements under Section 4.3 and Section 4.4 hereunder) provides for a “deferral of compensation”
within the meaning of Section 409A of the Code, such amounts shall be reimbursed strictly in accordance with Section 409A of the Code and Treasury Regulation 1.409A-3(i)(1)(iv), including the following requirements: (i) the amount
eligible for reimbursement or payment under such plan or arrangement in one calendar year may not affect the amount eligible for reimbursement or payment in any other calendar year (except that a plan providing medical or health benefits may impose
a generally applicable limit on the amount that may be reimbursed or paid), (ii) subject to any shorter time periods provided herein or the applicable plans or arrangements, any reimbursement or payment of an expense under such plan or
arrangement must be made on or before the last day of the calendar year following the calendar year in which the expense was incurred; and (iii) any such reimbursement or payment may not be subject to liquidation or exchange for another
benefit. 
 (vi) By accepting this Agreement, Executive hereby agrees and acknowledges that the Company does not make any representations
with respect to the application of Section 409A of the Code to any tax, economic or legal consequences of any payments payable to Executive hereunder. Further, by the acceptance of this Agreement, Executive acknowledges that (A) Executive
has obtained independent tax advice regarding the application of Section 409A of the Code to the payments due to Executive hereunder, (B) Executive retains full responsibility for the potential application of Section 409A of the Code
to the tax and legal consequences of payments payable to Executive hereunder and (C) the Company shall not indemnify or otherwise compensate Executive for any violation of Section 409A of the Code that may occur in connection with this
Agreement. The parties agree to cooperate in good faith to amend such documents and to take such actions as may be necessary or appropriate to (i) exempt the compensation and benefits payable under this Agreement from Section 409A of the
Code and/or preserve the intended tax treatment of such compensation and benefits, or (ii) comply with Section 409A of the Code; provided, however, that this Section 5.8 shall not create any obligation on the part of the
Company to adopt any such amendment or take any such other action. 
 6. Non-Competition, Non-Solicitation and Confidentiality and
Non-Disclosure.  
 6.1 Non-Competition, Non-Solicitation. The Executive hereby covenants and agrees that during the Term of the
Executive’s employment hereunder and for a period of one (1) year thereafter, Executive shall not, directly or indirectly: (i) own any interest in, operate, join, control or participate as a partner, director, principal, officer or
agent of, enter into the employment of, act as a consultant to, or perform any services for any entity (each a “Competing Entity”) which has material operations which compete with any business in which the Company or any of its
subsidiaries is then engaged or, to the then existing knowledge of the Executive, proposes to engage; (ii) solicit any customer or client of the Company or any of its subsidiaries (other than on behalf of the Company) with respect to any
business in which the Company or any of its subsidiaries is then engaged or, to the then existing knowledge of the Executive, proposes to engage; or (iii) induce or encourage any employee of the Company or any of its subsidiaries to leave the
employ of the Company or any of its subsidiaries; provided, that the Executive may, solely as an investment, hold not more than five percent (5%) of the combined voting securities of any publicly-traded corporation or other business
entity. The foregoing covenants and agreements of the Executive are referred to herein as the “Restrictive Covenant.” The Executive acknowledges that he has carefully read and considered the provisions of the Restrictive Covenant
and, having done so, agrees that the restrictions set forth in this Section 6.1, including without limitation the time period of restriction set forth above, are fair and reasonable and are reasonably required for the protection of the
legitimate business and economic interests of the Company. The Executive further acknowledges that the Company would not have entered into this Agreement absent Executive’s agreement to the foregoing. In the event that, notwithstanding the
foregoing, any of the provisions of this Section 6.1 or any parts hereof shall be 

  
 6 

 
held to be invalid or unenforceable, the remaining provisions or parts hereof shall nevertheless continue to be valid and enforceable as though the invalid or unenforceable portions or parts had
not been included herein. In the event that any provision of this Section 6.1 relating to the time period and/or the area of restriction, if any, and/or related aspects shall be declared by a court of competent jurisdiction to exceed the
maximum restrictiveness such court deems reasonable and enforceable, the time period and/or area of restriction and/or related aspects deemed reasonable and enforceable by such court shall become and thereafter be the maximum restrictions in such
regard, and the provisions of the Restrictive Covenant shall remain enforceable to the fullest extent deemed reasonable by such court. The portion of the payments set forth in Section 5.4 or 5.5, as applicable, that is allocable to the value of
the non-compete provisions set forth in this Section 6.1 shall be determined consistent with Section 1.280G-1 Q/A 9, and 40-44 of the Treasury Regulations. 

6.2 Confidentiality and Non-Disclosure. In consideration of the rights granted to the Executive hereunder, the Executive hereby agrees
that during the term of this Agreement and thereafter to hold in confidence all information concerning the Company or its business, including, but not limited to contract terms, financial information, operating data, or business plans or models,
whether for existing, new or developing businesses, and any other proprietary information (hereinafter, collectively referred to as the “Proprietary Information”), whether communicated orally or in documentary or other tangible
form. The parties to this Agreement recognize that the Company has invested considerable amounts of time and money in attaining and developing all of the information described above, and any unauthorized disclosure or release of such Proprietary
Information in any form would irreparably harm the Company. 
 6.3 Equitable Relief. The Executive agrees that it would be impossible
to adequately compensate the Company and its subsidiaries for the damage suffered by the Company or its subsidiaries as a result of Executive’s breach of any of the covenants and obligations set forth in this Section 6. Accordingly, the
Executive agrees that if the Executive breaches any such covenants and obligations, the Company or its subsidiaries may, in addition to any other right or remedy available, obtain an injunction from a court of competent jurisdiction restraining such
breach or threatened breach and to specific performance of any such provision of this Agreement. The Executive further agrees that no bond or other security shall be required in obtaining such equitable relief and the Executive hereby consents to
the issuance of such injunction and to the ordering of specific performance. 
 7. Indemnification. The Company shall indemnify the
Executive to the fullest extent permitted by law (including a payment of expenses in advance of final disposition of a proceeding) as in effect at the time of the subject act or omission, or by the Charter or Bylaws of the Company as in effect at
such time, or by the terms of any indemnification agreement between the Company and the Executive, whichever affords greatest protection to the Executive, and the Executive shall be entitled to the protection of any insurance policies the Company
may elect to maintain generally for the benefit of its officers or, during the Executive’s service in such capacity, directors (and to the extent the Company maintains such an insurance policy or policies, in accordance with its or their terms
to the maximum extent of the coverage available for any company officer or director), against all costs, charges and expenses whatsoever incurred or sustained by the Executive (including but not limited to any judgment entered by a court of law) at
the time such costs, charges and expenses are incurred or sustained, in connection with any action, suit or proceeding to which the Executive may be made a party by reason of his being or having been an officer or employee of the Company, or serving
as an officer or employee of an affiliate of the Company, at the request of the Company, other than any action, suit or proceeding brought against the Executive by or on account of his breach of the provisions of any employment agreement with a
third party that has not been disclosed by the Executive to the Company. The provisions of this Section 7 shall specifically survive the expiration or earlier termination of this Agreement. 

  
 7 

 8. Payment of Financial Obligations. The payment or provision to the Executive by the
Company of any remuneration, benefits or other financial obligations pursuant to this Agreement shall be allocated among the REIT, the Employer and any subsidiary or affiliate thereof in such manner as such entities determine in order to reflect the
services provided by the Executive to such entities. 
 9. Notices. Any notice required or desired to be given under this Agreement
shall be in writing and shall be delivered personally, transmitted by facsimile or mailed by registered mail, return receipt requested, or delivered by overnight courier service and shall be deemed to have been given on the date of its delivery, if
delivered, and on the third (3rd) full business day following the date of the mailing, if mailed, to each of the parties thereto at the following respective addresses or such other address as may be specified in any notice delivered or mailed
as above provided: 
 i) If to the Executive, to his then current address on the Company’s books and records. 

ii) If to the Company, the REIT or the Employer, to: 

Corrections Corporation of America 

10 Burton Hills Boulevard 

Nashville, Tennessee 37215 

Attention:                      

Facsimile: (615) 263-3010 

10. Clawback. The Executive agrees that compensation paid or payable to the Executive pursuant to this Agreement shall, to the extent
applicable, be subject to (i) the provisions of any claw-back policy adopted by the Company from time to time, including, without limitation, any claw-back policy adopted to comply with the requirements of the Dodd-Frank Wall Street Reform and
Consumer Protection Act and any rules or regulations promulgated thereunder, and (ii) any other claw-back requirements under applicable law. 

11. Waiver of Breach. The waiver by either party of any provision of this Agreement shall not operate or be construed as a waiver of
any subsequent breach by the other party. 
 12. Assignment. The rights and obligations of the Company under this Agreement shall
inure to the benefit of and shall be binding upon the successors and assigns of the Company. The Executive acknowledges that the services to be rendered by him are unique and personal, and the Executive may not assign any of his rights or delegate
any of his duties or obligations under this Agreement. 
 13. Entire Agreement. This instrument contains the entire agreement of the
parties and supersedes in full and in all respects any prior oral or written agreement between the parties with respect to Executive’s employment with the Company (including, without limitation the Prior Agreement). It may not be changed orally
but only by an agreement in writing signed by the party against whom enforcement of any waiver, change, modification, extension or discharge is sought, and in accordance with Section 409A of the Code. 

14. Controlling Law. This Agreement shall be governed and interpreted under the laws of the State of Tennessee. 

15. Headings. The sections, subjects and headings in this Agreement are inserted for convenience only and shall not affect in any way
the meaning or interpretation of this Agreement. 

  
 8 

 16. Enforcement. If the Executive is the prevailing party in any dispute among the parties
hereto regarding the enforcement of one or more of the provisions of this Agreement, then the Company shall reimburse the Executive for any reasonable attorneys’ fees and other expenses incurred by him in connection with such dispute. 

17. Acknowledgement. The Executive acknowledges (a) that he has consulted with or has had the opportunity to consult with
independent counsel of his own choice concerning this Agreement and has been advised to do so by the Company, and (b) that he has read and understands the Agreement, is fully aware of its legal effect, and has entered into it freely based on
his own judgment. 
 18. Counterparts. This Agreement may be executed in several counterparts, each of which shall be deemed to be an
original, but all of which together will constitute one and the same Agreement. Signatures delivered by facsimile or in .pdf format shall be deemed effective for all purposes. 

[signature page to follow] 

  
 9 

 IN WITNESS WHEREOF, the parties have executed this Agreement as of the day and year first
written. 
  

					
	EXECUTIVE:
		
	By:	 	  

	Name:
	
	REIT:
	
	CORRECTIONS CORPORATION OF AMERICA
		
	By:	 	  

		 	Name:	 	
		 	Title:	 	
	
	EMPLOYER:
	
	CCA OF TENNESSEE, LLC
		
	By:	 	  

		 	Name:	 	
		 	Title:	 	

  
 10 

 EXHIBIT A 

General Release 
 WAIVER
AND RELEASE OF CLAIMS 
 1. General Release. In consideration of the payments and benefits to be made under the Employment
Agreement, dated as of                     , 20    , to which Corrections Corporation of America (the
“REIT”), CCA of Tennessee, LLC (“Employer” and, together with the REIT, the “Company”) and
                     (the “Executive”) are parties (the “Agreement”), the Executive, with the intention of
binding the Executive and the Executive’s heirs, executors, administrators and assigns, does hereby release, remise, acquit and forever discharge the Company and its parents, subsidiaries and affiliates (collectively, the “Company
Affiliated Group”), their present and former officers, directors, executives, agents, shareholders, attorneys, employees and employee benefits plans (and the fiduciaries thereof), and the successors, predecessors and assigns of each of the
foregoing (collectively, the “Company Released Parties”), of and from any and all claims, actions, causes of action, complaints, charges, demands, rights, damages, debts, sums of money, accounts, financial obligations, suits,
expenses, attorneys’ fees and liabilities of whatever kind or nature in law, equity or otherwise, whether accrued, absolute, contingent, unliquidated or otherwise and whether now known, unknown, suspected or unsuspected which the Executive,
individually or as a member of a class, now has, owns or holds, or has at any time heretofore had, owned or held, against any Company Released Party (an “Action”) arising out of or in connection with the Executive’s service as
an employee, officer and/or director to any member of the Company Affiliated Group (or the predecessors thereof), including (i) the termination of such service in any such capacity, (ii) for severance or vacation benefits, unpaid wages,
salary or incentive payments, (iii) for breach of contract, wrongful discharge, impairment of economic opportunity, defamation, intentional infliction of emotional harm or other tort and (iv) for any violation of applicable state and local
labor and employment laws (including, without limitation, all laws concerning harassment, discrimination, retaliation and other unlawful or unfair labor and employment practices), any and all Actions based on the Employee Retirement Income Security
Act of 1974 (“ERISA”), any penalties, taxes or interest assessed under Section 409A of the Code and any and all Actions arising under the civil rights laws of any federal, state or local jurisdiction, including, without
limitation, Title VII of the Civil Rights Act of 1964 (“Title VII”), the Americans with Disabilities Act (“ADA”), Sections 503 and 504 of the Rehabilitation Act, the Family and Medical Leave Act and the Age
Discrimination in Employment Act (“ADEA”), excepting only: 
 (a) rights of the Executive under this Waiver and Release of
Claims and to severance payments and benefits under Section 5 of the Agreement; 
 (b) rights of the Executive relating to equity
awards held by the Executive as of the Executive’s date of termination; 
 (c) the right of the Executive to receive benefits required
to be paid in accordance with applicable law; 
 (d) rights to indemnification the Executive may have (i) under applicable corporate
law, (ii) under the by-laws or charter of any Company Released Party or (iii) as an insured under any director’s and officer’s liability insurance policy now or previously in force; 

(e) claims (i) for accrued or vested benefits under any health, disability, retirement, supplemental retirement, deferred compensation,
life insurance or other, similar employee benefit plan or arrangement of the Company Affiliated Group and (ii) for earned but unused vacation pay through the date of termination in accordance with applicable policy of the Company Affiliated
Group; and 

  
 11 

 (f) claims for the reimbursement of unreimbursed business expenses incurred prior to the date of
termination pursuant to applicable policy of the Company Affiliated Group. 
 2. No Admissions, Complaints or Other Claims. The
Executive acknowledges and agrees that this Waiver and Release of Claims is not to be construed in any way as an admission of any liability whatsoever by any Company Released Party, any such liability being expressly denied. The Executive also
acknowledges and agrees that the Executive has not, with respect to any transaction or state of facts existing prior to the date hereof, filed any Actions against any Company Released Party with any governmental agency, court or tribunal. 

3. Application to all Forms of Relief. This Waiver and Release of Claims applies to any relief no matter how called, including, without
limitation, wages, back pay, front pay, compensatory damages, liquidated damages, punitive damages for pain or suffering, costs and attorney’s fees and expenses. 

4. Specific Waiver. The Executive specifically acknowledges that the Executive’s acceptance of the terms of this Waiver and
Release of Claims is, among other things, a specific waiver of any and all Actions under Title VII, ADEA, ADA and any state or local law or regulation in respect of discrimination of any kind; provided, however, that nothing herein shall be
deemed, nor does anything herein purport, to be a waiver of any right or Action which by law the Executive is not permitted to waive under applicable law. 

5. Voluntariness. The Executive acknowledges and agrees that the Executive is relying solely upon the Executive’s own judgment;
that the Executive is over eighteen years of age and is legally competent to sign this Waiver and Release of Claims; that the Executive is signing this Waiver and Release of Claims of the Executive’s own free will; that the Executive has read
and understood the Waiver and Release of Claims before signing it; and that the Executive is signing this Waiver and Release of Claims in exchange for consideration that the Executive believes is satisfactory and adequate. In accordance with the
Older Workers Benefit Protection Act of 1990, the Executive also acknowledges and agrees that the Executive has been informed of his right to consult with legal counsel prior to executing this Waiver and Release of Claims and has been encouraged to
do so. 
 6. Complete Agreement/Severability. This Waiver and Release of Claims constitutes the complete and final agreement between
the parties and supersedes and replaces all prior or contemporaneous agreements, negotiations, or discussions relating to the subject matter of this Waiver and Release of Claims. All provisions and portions of this Waiver and Release of Claims are
severable. If any provision or portion of this Waiver and Release of Claims or the application of any provision or portion of the Waiver and Release of Claims shall be determined to be invalid or unenforceable to any extent or for any reason, all
other provisions and portions of this Waiver and Release of Claims shall remain in full force and shall continue to be enforceable to the fullest and greatest extent permitted by law. 

7. Acceptance and Revocability. In accordance with the Older Workers Benefit Protection Act of 1990, the Executive acknowledges that
the Executive has been given a period of [21 days] [45 days]1 within which to consider this Waiver and Release of Claims before executing it. The Executive may accept this Waiver and Release
of Claims at any time within this period of time by signing the 
  

	1 	 Applicable release consideration period to be inserted at the time of termination.

  
 12 

 
Waiver and Release of Claims and returning it to [            ] at the Employer. The Executive further acknowledges that he has
been given at least seven (7) days following the execution of this Waiver and Release of Claims to revoke this Waiver and Release of Claims and that this Waiver and Release of Claims shall not become effective or enforceable until the
expiration of such revocation period. The Executive may revoke the Executive’s acceptance of this Waiver and Release of Claims at any time within that seven calendar day period by sending written notice to
[            ] at the Employer. Such notice must be received by the Employer within the seven calendar day period in order to be effective and, if so received, would void this Waiver
and Release of Claims for all purposes. 
 8. Governing Law. Except for issues or matters as to which federal law is applicable, this
Waiver and Release of Claims shall be governed by and construed and enforced in accordance with the laws of the State of Tennessee without giving effect to the conflicts of law principles thereof. 

 

			
	Executive:
	
	  

		
	Date:	 	  

  
 13EXHIBIT 10.1

 EXHIBIT 10.1
 

 SETTLEMENT AGREEMENT
 

 This Settlement Agreement (the "Agreement"), effective as of the date that it is signed by the last party to sign it as indicated on the signature page (the "Effective Date"), is made by and between ITUS Corporation, formerly known as CopyTele, Inc., having a principal place of business at 900 Walt Whitman Road, 2nd Floor, Melville, New York 11747 ("ITUS"), and AU Optronics Corporation, having a principal place of business at No. 1, Li-Hsin Rd. 2, Hsinchu Science Park, Hsinchu 30078, Taiwan, Republic of China (''AUO") (collectively, the "Parties"' or either individually, a "Party").
  
 RECITALS
 

 WHEREAS, there is now pending before the International Centre for Dispute Resolution an arbitration entitled CopyTele, Inc. v. AU Optronics Corporation, Case No. 50-20-1300-0883 (the "Arbitration");
 

 WHEREAS, there is now pending in the United States District Court for the Northern District of California a civil action entitled CopyTele, Inc. v. AU Optronics Corp., et al., Case No. C-13-0380 EMC (the "AUO Action");
 

 WHEREAS, the Parties desire to finally resolve, settle and dismiss the Arbitration and the AUO Action, and provide certain consideration to each other on the terms and conditions set forth herein;
 

 WHEREAS, the Parties have entered into a Patent Assignment Agreement of even date herewith to effect the assignment of the EPD Patents (as defined below) from ITUS to AUO;
 

 NOW, THEREFORE, in consideration of the mutual covenants and promises contained in this Agreement, the Parties agree as follows:
 

 AGREEMENT
 

 1.
 DEFINED TERMS
 

 Unless otherwise defined, capitalized terms used herein shall have the following meanings:
 

 1.1
 "Affiliate" means a Person that, as of the Effective Date, is controlled by, or is under common control with a Party. For the purposes of this definition, "control" shall mean direct or indirect ownership of greater than fifty percent (50%) of the voting power, capital or other securities of a Person or the power otherwise to direct or cause the direction of the management and policies of the Person.
 

 1.2
 "Claims" means any and all claims, counterclaims, contribution claims, indemnity claims, demands, actions, causes of action, and all other claims of every kind and nature in law or equity, whether arising under state, federal, international or other law, all of the foregoing in connection with the EPD Agreement, and the nFED Agreement, whether such claims are absolute  or contingent, direct or indirect, known or unknown, and regardless of whether such claims were or were not asserted in the Arbitration or the AUO Action.
 

 1
 

 
  
 

 1.3
 "EPD" means electrophoretic display.
 

 1.4
 "EPD Agreement" means that certain contract titled "Exclusive License Agreement" entered into by and between CopyTele, Inc. and AU Optronics Corporation effective May 27, 2011. For the avoidance of doubt, the EPD Agreement was designated Hearing Exhibit 2 during the Arbitration, and bears control numbers COPYTELE-0000584-614.
 

 1.5
 "EPD Patents" means any and all patents and/or patent applications relating to EPD technology filed by, issued or assigned to, or otherwise owned or controlled by ITUS and/or its Affiliates, or predecessor(s) including CopyTele, Inc., anywhere in the world before the fifth anniversary of the effective date of the EPD Agreement, as well as all divisionals, continuations, continuations-in-part, reissues, reexaminations, utility models, foreign counterparts, parents and/or extensions in connection therewith. For the avoidance of doubt, the EPD Patents include without limitation the patents and patent applications identified in Appendix A. The Parties acknowledge that some of the EPD Patents have expired and/or have been abandoned, including without limitation, for failure to pay maintenance fees.
 

 1.6
 "nFED" means nano field emission display.
 

 1.7
 "nFED Agreement" means that certain contract titled "License Agreement" entered into by and between CopyTele Inc. and AU Optronics Corporation effective May 27. 2011. For the avoidance of doubt, the nFED Agreement was designated Hearing Exhibit 1 during the Arbitration, and bears control numbers COPYTELE-0000567-583.
 

 1.8
 "nFED Patents" means any and all patents and/or patent applications relating to nano field emission display technology filed by, issued or assigned to, or otherwise owned or controlled by ITUS and/or its Affiliates, or predecessor(s) including CopyTele. Inc., anywhere in the world, as well as all divisionals, continuations, continuations-in-part, reissues, reexaminations, utility models, foreign counterparts, parents and/or extensions in connection therewith. For the avoidance of doubt, the nFED Patents include without limitation the patents and patent applications identified in Appendix B.
 

 1.9
 "nFED Property" means the nFED Patents as defined herein, the nFED Technology, and subject Nano Display Products, as such terms are defined in the nFED Agreement, and any goodwill in connection therewith.
 

 1.10 
 "Person" means any individual or firm, association, organization, joint venture, trust, partnership, corporation. or other collective organization or entity.
 

 2.
 RELEASE
 

 

 2
 

 
 
 2.1
 Release. Each Party on behalf of itself and its Affiliates releases, acquits, and forever discharges the other Party and its Affiliates and their respective officers, directors, and employees of any and all Claims that existed, or are based on actions, transactions or circumstances that existed or took place at any time prior to the Effective Date, and further releases any and all Claims related to the Licensed Patents or Licensed Technology under the EPD Agreement, as those terms are defined respectively therein. This release includes without limitation Claims relating to the EPD Agreement and the nFED Agreement and any Claim either Party brought or could have brought in the Arbitration. By way of example and without any limitation, the released Claims include claims by ITUS or CopyTele, Inc. against AUO for alleged breach of contract, breach of the implied covenant of good faith and fair dealing, fraudulent inducement, negligent representation, unjust enrichment, unfair business practice, contract reformation, civil conspiracy, conspiracy to monopolize, patent infringement, accounting, and declaratory judgment, in connection with the EPD Agreement and the nFED Agreement. For the avoidance of doubt, each Party absolves the other of all Claims arising from the EPD Agreement and the nFED Agreement.
 

 2.2
 Unknown Claims. The Parties expressly waive and relinquish any and all rights under California Civil Code Section 1542, which provides as follows: A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR. The Parties expressly waive and release any rights and benefits which they have or may have under any similar law or rule of any other jurisdiction pertaining to the matter released herein.
 

 2.3
 Denial of Liability. The Parties acknowledge that they are entering into this Agreement to resolve disputed Claims, that nothing herein shall be construed to be an admission of liability, and that each Party expressly denies any liability to the other Party.
 

 3.
 DISMISSALS
 

 3.1
 Dismissal of the Arbitration. Within three (3) business days of (a) the Effective Date or (b) the date ITUS receives the full amount of the cash consideration due under both this Agreement and the Patent Assignment Agreement, whichever is later, ITUS shall cause its counsel to voluntarily dismiss the Arbitration, dismissing with prejudice any and all claims in their entirety, in a form substantially equivalent to the one attached in Appendix C. Such dismissal shall be effective as to all Claims asserted by ITUS or its predecessor(s) or that could have been asserted by ITUS or its predecessor(s). Each Party shall bear its own attorneys' fees, expenses, and costs relating to the Arbitration and the negotiation of this Agreement. Each Party shall remain liable for its portion of any outstanding Arbitration costs or fees.
 

 3.2
 Dismissal of the AUO Action. Within three (3) business days of (a) the Effective Date or (b) the date ITUS receives the full amount of the cash consideration due under both this Agreement and the Patent Assignment Agreement, whichever is later, the Parties shall jointly file a stipulation of dismissal requesting that the United States District Court presiding over the AUO Action issue an order dismissing with prejudice all claims and any counterclaims between the named parties in the AUO Action, each named party to bear its own attorneys' fees, expenses, and costs, in a form substantially equivalent to the one attached in Appendix D. The Parties agree to submit to the court all appropriate stipulations and proposed orders for extensions of time for all   due dates in the AUO Action so that neither Party is required to incur unnecessary expenses in the AUO Action between the Effective Date and the date the AUO Action is dismissed.
 

 3
 

 
  
 

 4.
 COVENANTS
 

 4.1
 For a period of two (2) years from the Effective Date, ITUS will not initiate, or directly or indirectly assist any Affiliate or third-party to initiate, any lawsuit or claim in any forum against AUO or its Affiliates, or their respective officers, directors or employees, alleging direct or indirect infringement by any of AUO's or its Affiliates' products or services of any patent or patent application filed by, issued or assigned to, or otherwise owned or controlled by ITUS or its Affiliates as of the Effective Date (including the nFED Patents), or of any divisionals, continuations, continuations-in-part, reissues, reexaminations, utility models, foreign counterpart, parent or extensions of said patents or patent applications (collectively, the "ITUS CNS Patents"). ITUS covenants that it shall only assign ownership or grant exclusive rights to any such ITUS CNS Patents under terms where the assignee or licensee expressly agrees in writing that any rights it obtains are subject to this Section 4, and all the limitations set out herein. Solely to the extent necessary to ensure that AUO and its Affiliates continue to have the benefit intended by the covenant not to sue set out in this Section 4, if ITUS: (a) assigns any ITUS CNS Patents to any third party; (b) fails to have the assignee expressly agree to take such assignment subject to the terms of this Section 4 and (c) such assignee asserts the ITUS CNS Patent(s) against AUO and its Affiliates, ITUS hereby grants to AU and its Affiliates a non-exclusive, non-transferable (other than as part of an assignment authorized under the terms of this Agreement) license under the ITUS CNS Patents, until the second anniversary of the Effective Date, to use, make, sell, offer to sell, import, and otherwise dispose of products and services and to practice methods in connection therewith. In the event AUO or its Affiliates or agents files any litigation or arbitration against ITUS or its Affiliates during the term of the covenant provided under Section 4.1 (and fails to dismiss such action within five (5) days written notice), then ITUS shall have the ability to terminate such covenant immediately upon written notice to AUO. Notwithstanding the foregoing, nothing in this Section 4 shall prevent either Party from filing an arbitration to enforce the terms of this Agreement, and such filing shall not permit ITUS to terminate the Section 4.1 covenant.
 

 4.2.
 Tolling of Damages. Potential damages (if any) shall toll uninterrupted during the two-year term of the covenants not to sue in Section 4.1 concerning the ITUS CNS Patents.
 

 4.3.
 Rights Run with the ITUS CNS Patents. Any and all rights under the covenants not to sue under Section 4.1 concerning the ITUS CNS Patents shall run with the ITUS CNS Patents and shall be binding on any successors-in-interest or assigns thereof.
 

 4.4.
 Neither Party shall assert against the other Party or its Affiliates laches, willfulness, equitable estoppel or any other equitable counterclaim and/or defense in any future cause of action or licensing negotiations related to the ITUS-CNS Patents to the extent such counterclaims and/or defenses are based on inactivity during the two-year term of the covenants not to sue in Section 4.1.
 

 

 4
 

 
 
  4.5.
 Termination of Covenant; Change of Control. If, after the Effective Date, either Party transfers an Affiliate to an acquirer, or spins out a Affiliate, or an Affiliate is otherwise divested or wound-down, such that such Entity is no longer an Affiliate, upon such event, the covenants not to sue under Section 4.1 of this Agreement with respect to such Affiliate shall be terminated as of the date that such entity no longer qualifies as an Affiliate.
 

 4.6. 
 No Prejudice Regarding Future Assertions and Defenses. Other than as specifically set forth herein, this Agreement shall not prejudice any claims or defenses which AUO or its Affiliates may assert in the event that any entity alleges that AUO or any Affiliate is liable in any respect for alleged infringement of the ITUS CNS Patents. Other than as specifically set forth herein, this Agreement shall not prejudice any claims or defenses that ITUS or its Affiliates may assert in the event that any entity alleges that ITUS or any Affiliate is liable in any respect for alleged infringement of patents owned by AUO or any Affiliate of AUO.
 

 4.7.
 ITUS and AUO acknowledge and agree that neither Party is obtaining a license to any of the other Parties' respective patents, and nothing contained in this Agreement shall be construed as conferring any rights by implication, estoppel or otherwise, under any copyrights, trademarks, trade names, trade secrets, mask work rights, moral rights or other non-patent intellectual property right, or any patents or patent applications, except as expressly stated herein. All rights not expressly granted under this Agreement are reserved and retained by the Party holding such right as of the Effective Date.
 

 4.8.
 Each Party covenants during the two-year term of the covenant not to sue in Section 4.1 not to use the permissible disclosure to another party of any part of this Agreement-as a basis for bringing a declaratory judgment action against the disclosing Party or its Affiliates.
 

 4.9.
 Each Party covenants not to cause, assist, fund, or contribute to the filing of re-examination requests, inter partes reviews or other judicial or administrative challenges with respect to any patents owned or controlled by the other Party or its Affiliates, unless such action, request, or challenge is in response to an assertion that is inconsistent with the rights granted under this Agreement. This Agreement shall not prevent either Party from responding to a valid subpoena from a third-party seeking information in its possession, custody or control.
 

 5.
 TERMINATION OF PRIOR AGREEMENTS
 

 5.1
 Termination of EPD Agreement. The Parties agree to and hereby do terminate and cancel in its entirety the EPD Agreement. For the avoidance of doubt, neither Party shall retain any rights or ongoing obligations under the EPD Agreement. ITUS acknowledges and agrees that the termination of the EPD Agreement shall not impact or terminate any sub-licenses granted by AUO under the terms of the EPD Agreement, or any other rights that may have existed prior to such termination.
 

 5.2
 Termination of nFED Agreement. The Parties agree to and hereby do terminate and cancel in its entirety the nFED Agreement. For the avoidance of doubt, neither Party shall retain any rights or ongoing obligations to each other under the nFED Agreement. AUO acknowledges that it no longer has any rights to the nFED Property, and represents and warrants that it has not transferred or granted any rights to the nFED Property to any third party. Neither AUO nor any of its Affiliates shall grant any covenants or rights, assignments, encumbrances, sub-licenses, cross-licenses, or other agreements concerning any of the nFED Property.
 

 5
 

 
  
 

 6. CONSIDERATION
 

 6.1
 Fees. In consideration of the rights granted it under Section 2.1, AUO shall pay to ITUS a fee in the amount of one million United States Dollars ($1,000,000), and in consideration of the rights granted it under Section 4. AUO shall pay to ITUS a fee in the amount of one million United States Dollars ($1,000,000). Such fees shall be payable in full on or before December 31, 2014. No part of any such fees is attributable to lost profits.
 

 6.2
 Payment. Unless otherwise agreed by ITUS in writing, AUO shall pay the Fee by wire transfer of immediately available funds to ITUS's designated bank account as follows, with any bank processing fees charged by Citibank to be borne solely by ITUS.
  
 Bank Name:                 Citibank, F.S.B.
 San Francisco Private Banking
 Bank Address:              One Sansome Street, 24th Floor
 San Francisco, California 94104
 ( 415) 627-6037
 Account No.:                Withheld
 ABA Routing No. :       Withheld
 To Credit:                     State Bar Attorney Client Trust, Lieff
 Cabraser Heimann & Bernstein
 
 
 6.3
 Taxes. All taxes imposed as a result of the existence or performance of this Agreement shall be borne and paid by the Party required to do so by applicable law; provided, however, that, if so required by applicable law, AUO shall either (a) withhold the amount of any national taxes levied by the Government of the Republic of China (Taiwan) on any payment by AUO hereunder, and shall promptly pay such amount to the appropriate tax authorities of the Government of the Republic of China (Taiwan) or (b) apply for the appropriate exemption. In either case, AUO shall ensure that ITUS receives the full amount set forth in Section 6.1 on or before December 31, 2014. ITUS shall provide AUO with reasonable assistance in either seeking an exemption or in obtaining a refund for any taxes paid, and any such refund shall go to AUO. ITUS will be responsible for payment of any non-Taiwanese taxes on its own net income arising from its receipt of the fees under Section 7.1.
 

 6.4
 Costs and Expenses. The Parties agree that each Party is responsible for its own attorneys' fees, expenses, and costs relating to the preparation and execution of this Agreement.
 

 7. WARRANTIES
 

 7.1
 Authorization. Each Party represents and warrants that it has the requisite power and authority to enter into this Agreement, to perform its obligations hereunder, and that the execution, delivery and performance of this Agreement has been duly authorized by all necessary corporate action on behalf of each Party.
 

 7.2
 No Conflicts. Each Party represents and warrants that it has not and will not enter into any other agreement or understanding in conflict with the provisions contained in this Agreement.
 

 8. TERM AND TERMINATION
 

 Once the fees provided for under Section 6.1 have been paid, this Agreement shall remain in full force and effect, except as limited according to the time periods specified herein, and shall not be terminated except by the mutual written consent of the Parties.
 

 6
 

 
  
 

 9. ASSIGNABILITY
 

 9.1
 Assignment of Rights or Agreement. Except as expressly set forth herein, neither Party may grant or assign any rights or delegate any duties under this Agreement to any third party (whether voluntarily or involuntarily, by merger. consolidation, dissolution, operation of law or any other manner) without the prior written consent of the other Party, except that, unless otherwise set forth herein, this Agreement may be assigned without such consent in the event of a merger, acquisition or sale of substantially all assets to which this Agreement relates, provided however that following any such merger, acquisition, or sale, the covenant not to sue set forth in Section 4.1 above, if still applicable, shall only continue to apply to AUO's and/or its Affiliates' products and services, and not the products and services of any acquired or acquiring entity or merging company.
 

 9.2
 Successors and Assigns. Any attempted assignment or grant in contravention of Section 9 shall be null and void. Subject to the foregoing, this Agreement shall be binding upon, inure to the benefit of and be enforceable by the Parties and their permitted successors and assigns.
 

 10. CONFIDENTIALITY
 

 10.1 
 Confidentiality Obligation. The terms of this Agreement and all correspondence relating to this Agreement. as well as any non-public financial information exchanged by the Parties hereunder, are confidential, and no Party shall disclose such terms and particulars to any third party except: (i) to the extent that the disclosure of the terms of this Agreement and/or the Parties' Patent Assignment Agreement may be required by applicable law, regulation or order of a governmental authority of competent jurisdiction (including any securities regulatory body or exchange, (ii) during the course of litigation or arbitration so long as the disclosure of such information is subject to the same restrictions as is the confidential information of the other litigating parties, and such restrictions are embodied in a court or arbitral tribunal-entered protective order limiting disclosure to outside counsel and such disclosing Party, (iii) in confidence to the professional legal and financial counsel representing such Party, (iv) in confidence to a Party's Affiliates or to any Person protected by the release set forth in Section 2, or (v) in  confidence to a potential acquirer, investor or lender in connection with a merger, acquisition or financing and its professional legal and financial counsel. Notwithstanding the foregoing, to the extent that the terms of this Agreement and/or the Parties' Patent Assignment Agreement have been disclosed publicly to a governmental authority, the terms of the agreements may no longer be treated as confidential information.
 

 10.2 
 Publicity. Neither party shall issue any press release regarding this Agreement (except as permitted in Section 10.1 with respect to required filings with a governmental authority) other than the single press release attached in Appendix E. Nothwithstanding this provision, nothing in this Agreement is intended to or shall limit either Party's ability to disclose the terms of this Agreement as required by law to a governmental authority such as a securities regulatory body. In addition, nothing in this Section 10 is intended to or shall limit either Party's ability to truthfully answer any questions about or discuss the terms of this Agreement with third parties and/or shareholders.
 

 7
 

 
  
 

 11. NOTICES
 

 All notices, consents, waivers and other communications under this Agreement must be both in writing and by email and written notices shall be deemed to have been duly given: (a) when delivered by hand (including by overnight courier) (with written confirmation of receipt), or (b) within one (1) business day (i.e., a day other than a Saturday or Sunday on which banks are open for business in both New York City and Taipei), if sent by a delivery service (prepaid, receipt requested) or internationally recognized overnight courier or (c) within three (3) business days, if sent by registered or certified mail (postage prepaid, return receipt requested), in each case to the appropriate addresses set forth below (or to such other addresses as a Party may designate by written notice to the other Parties):
 

 

 

 For AUO:
 AU Optronics Corporation Attention: Hank Liu 
 No. 1. Li-Hsin Rd. 2 Hsinchu Science Park Hsinchu 30078
 Taiwan. Republic of China hank.m.liu@auo.com linh.ha@auo.com
 

 With a copy to:
 Lawrence Gotts
 Latham & Watkins LLP
 555 Eleventh Street, NW
 Suite 1000
 Washington, D.C. 20004-1304
 

 With a copy to:
 lawrence.gotts@lw.com
  
 For ITUS:
 ITUS Corporation
 Attention: Robert Berman, CEO 12100 Wilshire Blvd, Suite 1275 Los Angeles, CA 90025
 (310) 309-2122
 rberman@ituscorp.com and tstender@ituscorp.com
 

 With a copy to:
 Eric B. Fastiff
 Lieff, Cabraser, Heimann & Bernstein, LLP
 275 Battery Street, 291h Floor
 San Francisco, CA 94111-1000
 

 With a copy to: 
 efastiff@lchb.com
 

 8
 

 
 
 12. 
 MISCELLANEOUS
 

 12.1 
 No Agency; No Joint Venture. Nothing in this Agreement is intended, or shall be deemed to constitute, a partnership, agency, employer-employee, or joint venture relationship between the Parties. Neither Party shall incur any debts or make any commitments for the other arising out of or related to this Agreement. There is no fiduciary duty or special relationship of any kind between the Parties arising out of or related to this Agreement. Each Party expressly disclaims any reliance on any act, word, or deed of the other Party in entering into this Agreement.
 

 12.2 
 Severability. To the extent that any term, condition or provision of this Agreement is held to be invalid, illegal or otherwise unenforceable under applicable law, then such term, condition or provision shall be deemed amended only to the extent necessary to render such term, condition or provision enforceable under applicable law, preserving to the fullest extent possible the intent and agreements of the parties set forth herein; in the event that such term, condition or provision cannot be so amended as to be enforceable under applicable law, then such term, condition or provision shall be deemed excluded from this Agreement and the other terms, conditions and provisions hereof shall remain in full force and effect as if such unenforceable term, condition or provision had not been included herein so long as the Agreement still expresses the intent of the Parties. However, if the intent of the Parties cannot be preserved, this Agreement shall be renegotiated.
 

 12.3 
 Entire Agreement; Amendment. This Agreement cannot be modified, terminated or amended in any respect orally or by conduct of the Parties. Any termination, modification, or amendment may be made only by a writing signed by all Parties.
 

 12.4 
 Waiver. The forbearance, delay, or failure of a Party in enforcing any of the terms and conditions of this Agreement shall not constitute a waiver to enforce its rights with respect to the same or any other terms and conditions, or to otherwise affect or restrict the rights, powers or remedies of any Party.
 

 12.5 
 Counterparts. This Agreement may be executed in several counterparts, each of which is deemed to be an original but all of which constitute a one and the same instrument.
 

 12.6 
 Interpretation. The headings inserted in this Agreement are for reference only and are not intended to form any part of the operative portion of this Agreement, and they shall not be employed in the interpretation or application of this Agreement. Each Party and counsel have reviewed and approved this Agreement, and accordingly any presumption or rule of construction permitting ambiguities to be resolved against the drafting Party shall not be employed in the interpretation or application of this Agreement. "Including" and "include" always mean "including" or "include" without limitation.
 

 12.7 
 Arbitration: Governing Law. The rights and obligations of the Parties under this Agreement shall be governed by and construed in accordance with laws of California. Any dispute in connection with this Agreement shall be submitted to arbitration administered by the American Arbitration Association under its Commercial Arbitration Rules. The place of arbitration shall be San Francisco, California. The arbitration shall be heard by the same panel that heard the Arbitration (to the extent such panel is available). In the event of any such action to enforce or interpret the terms of this Agreement, the prevailing party shall be entitled, in addition to its court costs, to its reasonable attorneys' fees, including without limitation, the costs, expenses and attorneys' fees on any appeal.
 

 9
 

 
  
 

 12.8 
 Integration. This Agreement sets forth the entire understanding of the Parties with respect to the subject matter hereof and supersedes any prior or collateral agreements, negotiations and communications in connection with the subject matter covered herein, whether oral or written, and any warranty, representation, promise, or condition in connection therewith not incorporated herein shall not be binding upon either Party or its Affiliates.
 

 

 [Rest of Page Left Blank; Signature Page Follows]
 

 

 

 10
 

 
 This Agreement has been duly executed by the Parties to be effective as of the Effective Date.
 

 	 	
	 AU OPTRONICS CORPORATION 
	 ITUS CORPORATION 

	 

	 

	 By: /s/ Linh Ha
	 By: /s/ Robert A. Berman 

	 Name: Linh Ha 
	 Name: Robert A. Berman 

	 Its: General Counsel-Americas 
	 Its: CEO 

	 Dated: 12-28-14
	 Dated: December 29, 2014

 

 

 

 

 

 

 

 

 
 Appendix A - EPD Patents
 

 	 	 	 	
	 Patent #
	 Application #
	 Title
	 Countries

	 NOA
	 14/269,099
	 Dual particle electrophoretic display and method of manufacturing same.
	 US

	 8754845
	 13/589,613
	 Manufacturing an EPD
	 US

	 8629833
	 12/932,191
	 SINGLE PARTICLE ELECTROPHORETIC DISPLAY AND METHOD OF MANUFACTURING SAME
	 US

	 8519944
	 12/932,088
	 Dual particle electrophoretic display and method of manufacturing same.
	 US

	 8436807
	 12/931,983
	 Single particle electrophoretic display and method of manufacturing same.
	 US

	 8248362
	 12/932,089
	 Method of Manufacturing an Electrophoretic display
	 US

	 7289101
	 09/640,514
	 Multi-color electrophoretic image display
	 US

	 6194488
	 09/259,769
	 Method for making polymer-coated pigment particles using initiator-treated pigments
	 US

	 6117368
	 08/361,891
	 Black and white electrophoretic particles and method of manufacture
	 US

	 6113810
	 08/383,667
	 Methods of preparing electrophoretic dispersions containing two types of particles with different colors and opposite charges
	 US

	 5964935
	 08/916,895
	 Initiator-treated pigment particles and method for preparing same
	 US

	 4889603
	 07/281,701
	 Methods of Eliminating Gas Bubbles in an Electrophoretic Display
	 US

	 4892607
	 07/208,854
	 Chip Mounting Technique for Display Apparatus
	 US

	 4947157
	 07/252,598
	 Apparatus and Methods for Pulsing the Electrodes of an Electrophoretic Display for Achieving Faster Display Operation
	 US

	 4947159
	 07/182,436
	 Power Supply Apparatus Capable of MultiS Mode Operation for an Electrophoretic Display Panel
	 US

	 5006212
	 07/166,430
	 Methods Enabling Stress Free Patterning of Chrome on Layers of Organic Polymers
	 US

	 5077157
	 07/440,787
	 Methods of Fabricating Dual Anode Flat Panel Electrophoretic Display
	 US

	 5250938
	 07/960,572
	 Electrophoretic Display Having Enhanced Operation
	 US

	 5254981
	 07/975,119
	 Electrophoretic Display (EPID) Employing Grey Scale Capability Utilizing Area Modulation
	 US

	 5266937
	 07/796,759
	 Method of Writing Data to an Electrophoretic Display Panel
	 US

	 5276438
	 07/794,969
	 Electrophoretic Display Panel with Internal Mesh Background Screen
	 US

	 5279511
	 07/964,350
	 Method of filling an Electrophoretic Display
	 US

	 5279694
	 07/950,640
	 Chip Mounting Techniques for Display Apparatus
	 US

	 5293528
	 07/841,380
	 Electrophoretic Display Panel & Associated Methods for Providing Single Pixel Erase Capability
	 US

	 5298833
	 07/901,755
	 Black Electrophoretic Particles for an Electrophoretic Image Display
	 US

	 5302235
	 07/719,021
	 Dual Anode Flat Panel Electrophoretic Display Apparatus
	 US

	 5304439
	 08/006,471
	 Electrophoretic Display Panel with Interleaved Local Anode
	 US

	 5315312
	 08/108,846
	 Electrophoretic Display Panel with Tapered Grid Insulators
	 US

	 5345251
	 08/002,623
	 Electrophoretic Display Panel with Interleaved Cathode and Anode
	 US

	 5359346
	 08/088,615
	 Electrophoretic Display Panel and Associated Methods for Blinking Displayed Characters
	 US

	 5380362
	 08/092,749
	 Suspension for Use in Electrophoretic Image Display System
	 US

	 5403518
	 08/161,315
	 Formulation for Improved Electrophoretic Display Suspensions and Related Methods
	 US

	 5411656
	 08/106,395
	 Gas Absorption Additives for Electrophoretic Suspensions
	 US

	 5412398
	 08/208,136
	 Electrophoretic Display Panel and Associated Methods for Blinking Displayed Characters
	 US

	 5450069
	 08/264,412
	 Data/ Facsimile Telephone Subset apparatus Incorporating Electrophoretic Displays- (File Wrapper Continuing Procedure)
	 US

	 5459776
	 08/184,852
	 Data/ Facsimile Telephone Subset apparatus Incorporating Electrophoretic Displays- (File Wrapper Continuing Procedure)
	 US

	 5460688
	 08/058,532
	 Dual Anode Flat Panel Electrophoretic Display Apparatus
	 US

	 5707738
	 08/306,134
	 Black Electrophoretic Particles and Method of Manufacture
	 US

	 5783614
	 08/803,716
	 Polymeric -Coated Dielectric Particles and Formulation and Method for Preparing Same
	 US

	 5835577
	 08/363,543
	 Multi-Functional Personal Telecommunications Apparatus
	 US

	 5932633
	 08/916,855
	 Method for Making Polymer-Coated Pigment Particles Using Initiator Treated Pigments
	 US

	 6148066
	 09/149,324
	 Multi-Functional Personal Telecommunications Apparatus
	 US

	 6198809
	 09/096,800
	 Multi-Functional Personal Telecommunications Apparatus
	 US

	 CN1138385A
	 95191133.3
	 1. Portable Telecommunications Device removable Electrphoretic Display (1CN)
	 China

	 CN1149894A
	 95193241.1
	 2. Fluorinated Dielectric Suspension For Electryphoretic Image Displays and related Methods (2CN)
	 China

	 CN1250528A
	 98803360.7
	 3. High Speed Solid State Optical Display (4CN)
	 China

	 CN1250457A
	 98803274.0
	 4. Polymeric Coated Dialectric Particles and Formulation and Method for Preparing Same (5CN)
	 China

	 2958114
	 502927
	 1. Electrophoretic Display Employing Grey Scale Capability Utilizing Area Modulation (2J)
	 Japan

	 2586181
	 11224/95
	 2. Semitransparent Electrophoretic Information Displays (EPID) Employing Mesh-Like Electrodes (6J)
	 Japan

	 2738462
	 510302/91
	 3. Methods of Fabricating Dual Anode, Flat Panel Electrophoretic Display Apparatus (7J)
	 Japan

	 2916260
	 511968/92
	 

 4. Electrophoretic Display Panel with Tapered Grid Insulators and Associated Methods (10J)
	 Japan

	 2603037
	 507403/92
	 

 5. Electrophoretic Display Panel with Plural Electrically Independent Anode Elements (12J)
	 Japan

	 2994750
	 515659/91
	 6. Electrophoretic Display Panel with Internal Mesh Background Screen (13J)
	 Japan

	 3002537
	 505133/92
	 7. Methods of Writing Data to an Electrophoretic Display Panel (14J)
	 Japan

	 2825653
	 506132/92
	 8. Electrode Structure for an Electrophoretic Display Apparatus (15J)
	 Japan

	 2740048
	 516215
	 9. Electrophoretic Display Panel with Interleaved Cathode and Anode (23J)
	 Japan

	 2916260
	 511968
	 10. Electrophoretic Display Panel with Tapered grid insulators and Associated Methods (10J)
	 Japan

	 3192150
	 515676
	 

 11. Formulation for Improved Electrophoretic Display Suspension and Related Methods (31J)
	 Japan

	 0325013
	 88300448.3
	 

 1. Electrophoretic Display Panel Apparatus (1 EU)*
	 BE DE FR GB IT NL SE

	 0344367
	 

 

 88304003.2
 

 

 

 

 

	 

 2. Monolithic Flat Panel Display Apparatus (2 EU)
	 BE DE FR GB IT NL SE

	 0448853
	 90303210.0
	 3. Semi Transparent Electrophoretic Information Displays (EPID) Employing Mesh Like Electrodes (3 EU)
	 AT BE CH DE DK ES FR GB GR IT LI LU NL
 SE

	 0570995
	 93112534.8
	 4. Semi Transparent Electrophoretic Information Displays (EPID) Employing Mesh Like Electrodes (3A EU)
	 AT BE CH DE DK ES FR GB GR IT LI LU NL
 SE

	 0396247
	 90303243.1
	 5. Dual Anode Flat Panel Electrophoretic Display Apparatus (5 EU)
	 AT BE CH DE DK ES FR GB GR IT LI LU NL
 SE

	 0417362
	 89309376.5
	 6. Data/Facsimile Telephone Subset Apparatus Incorporating Electrophoretic Display (6 EU)
	 BE DE FR GB IT NL SE

	 0363030
	 89309317.9
	 7. Apparatus and Methods for Pulsing the Electrodes of an Electrophoretic Display for Achieving faster Display Operation (7 EU)
	 BE DE FR GB IT NL SE

	 0586373
	 91911607.9
	 8. Methods of Fabricating Dual Anodes Flat Panel Electrophoretic Displays (8 EU)
	 BE DE FR GB NL

	 0595812
	 92902841.3
	 9. Electrophoretic Display Employing Grey Scale Capability Utilizing Area Modulation (9 EU)
	 DE FR GB

	 0600878
	 91916261.0
	 10. Electrophoretic Display Panel with Internal Mesh Background Screen (10 EU)
	 BE DE FR GB NL

	 0604423
	 92904723.1
	 11. Method for Writing Data to an Electrophoretic Display Panel (11 EU)
	 BE DE FR GB

	 0607145
	 92905859.2
	 12. Electrode Structure for an Electrophoretic Display Apparatus (12 EU)
	 BE DE FR GB NL

	 0577738
	 92910099.8
	 13. Electrophoretic Display Panel with Semi Conductor Coated Eliments (13 EU)
	 EE DE FR GB NL

	 0575475
	 92907776.6
	 14. Electrophoretic Display Panel with Plural Electricrically Independent Anode Elements (15 EU)
	 BE DE FR GB NL

	 0601075
	 92919087.4
	 15. Electrophoretic Display Panel with Single Character Erasure (16 EU)
	 NL FR GB BE

	 0601072
	 92919073.4
	 16. Electrophoretic Display Panel with Interleaved Local Anode (17 EU)
	 BE DE FR GB NL

	 0632919
	 93904694.2
	 17. Electrophoretic Display Panel for Blinking Displayed Characters (18 EU)
	 BE DE FR GB IT NL

	 0628194
	 93904812.0
	 18. Electrophoretic Display Panel and Associated Methods Providing Single Pixel Erase Capability (19 EU)
	 BE DE FR GB IT NL

	 0679284
	 94905600.6
	 19. Electrophoretic Display Panel with Interleaved Cathode Anode (20 EU)
	 BE DE FR GB IT NL

	 0746639
	 94901175.3
	 20. Method of Filling an Electrophoretic Display (22 EU)
	 BE DE FR GB IT NL

	 0685101
	 94907380.3
	 21. Electrophoretic Display with Arc Driven Individual Pixels (23 EU)
	 BE DE FR GB IT NL

	 0708798
	 94920792.2
	 22. Suspension for Use an Electrophoretic Image Display Systems (32 EU)
	 BE DE FR GB IT NL

	 Abandoned
	 12/932,158
	 Four Color Electrophoretic Display
	 US

	 4598960
	 06/728,602
	 Methods and apparatus for connecting closely spaced
	 US

	 4655897
	 06/670,571
	 Electrophoretic display panels and associated methods
	 US

	 4732830
	 06/882,271
	 Electrophoretic Display Panels and Associated Methods
	 US

	 4742345
	 06/799,458
	 Electrophoretic Display Panel Apparatus and Methods Therefor
	 US

	 4746917
	 06/885,538
	 Methods and Apparatus for Operating Electrophoretic Display Between a Display and Non-Display Mode
	 US

	 4772820
	 06/905,570
	 Monolithic Flat Panel Display Apparatus
	 US

	 4833464
	 07/096,037
	 Electrophoretic Information Display Apparatus (EPID) Employing Gray Scale Capability
	 US

	 4850919
	 07/171,114
	 Monolithic Flat Panel Display Apparatus and Methods for Fabrication
	 US

	 4870677
	 07/093,374
	 Data/ Facsimile Telephone Subset Apparatus Incorporating Electrophoretic Displays
	 US

	 5028841
	 07/383,278
	 Chip Mounting Technique for Display Apparatus CIP-Div. App.
	 US

	 5041824
	 07/318,751
	 Semitransparent Electrophoretic Information Display (EPID) Employing Mesh-Like Electrodes
	 US

	 5053763
	 07/345,825
	 Dual Anode Flat Panel Electrophoretic Display Apparatus
	 US

	 5066946
	 07/375,056
	 Electrophoretic Display Panel with Selective Line Erasure
	 US

	 5177476
	 07/746,865
	 Methods of Fabricating Dual Anode Flat Panel Electrophoretic Display
	 US

	 5187609
	 07/675,733
	 Electrophoretic Display Panel with Semiconductor Coated Elements
	 US

	 5223115
	 07/752,184
	 Electrophoretic Display with Single Character Erasure
	 US

	 5223823
	 07/950,966
	 Electrophoretic Display Panel with Plural Electrically Independent Anode Elements
	 US

	 5174882
	 07/796,761
	 Electrode Structure for an Electrophoretic Display Apparatus
	 US

	 5216416
	 07/746,854
	 Electrophoretic Display Panel with Interleaved Local Anode
	 US

	 5247290
	 07/795,659
	 Method of Operation for Reducing Power, Increasing Life and Improving Performance of EPID's
	 US

	 5360689
	 08/065,572
	 Colored Polymeric Dielectric Particles & Methods of Manufacture
	 US

	 5402145
	 08/018,111
	 Electrophoretic Display Panel with Arc Driven Individual Pixels
	 US

	 5467107
	 08/313,987
	 Electrophoretic Display Panel with Selective Character Addressability
	 US

	 5498674
	 08/241,349
	 Colored Polymeric Dielectric Particles & Methods of Manufacture
	 US

	 5499038
	 08/180,197
	 Method of Operation for Reducing Power, Increasing Life and Improving Performance of EPID's
	 US

	 5508720
	 08/190,648
	 Portable Telecommunication Device with Removable Electrophoretic Display
	 US

	 5561443
	 08/304,943
	 Electrophoretic display panel with arc driven individual pixels
	 US

	 5573711
	 08/561,091
	 Planar fluorinated dielectric suspensions for electrophoretic image displays and related methods
	 US

	 5587242
	 08/561,249
	 Colored polymeric dielectric particles and method of manufacture
	 US

	 5627561
	 08/630,555
	 Electrophoretic display panel with selective character addressability
	 US

	 5643673
	 08/141,867
	 Black electrophoretic particles and method of manufacture
	 US

	 5869558
	 08/863,323
	 Black electrophoretic particles and method of manufacture
	 US

	 DES. 383750
	 29/052,063
	 Personal Telecommunications Terminal
	 US

 

 

 

 

 
 APPENDIX B - nFED Patents
 

 	 	 	
	 Patent #
	 App No.
	 Title

	 8,604,680
	 12/660,730
	 Reflective Nanostructure Field Emission Display

	 8,552,632
	 13/184,510
	 Active matrix phosphor cold cathode display

	 8,469,761
	 12/924,422
	 Apparatus and method of rapid sealing of a flat panel display

	 8,228,352
	 12/322,153
	 Predetermined voltage applications for operation of a flat panel display

	 8,223,101
	 12/290,282
	 Active matrix phosphor cold cathode display

	 8,222,813
	 12/079,658
	 Matrix phosphor cold cathode display employing secondary emission

	 8,148,889
	 12/798,800
	 Low voltage phosphor with film electron emitters display device

	 8,120,550
	 11/499,841
	 Edge emission electron source and TFT pixel selection

	 8,013,512
	 12/798,808
	 Flat panel display incorporating a control frame

	 8,008,849
	 12/806,441
	 Flat panel display incorporating control frame

	 7,918,703
	 12/378,784
	 Flat panel display having a control frame pedestal and method of making same

	 7,883,389
	 11/704,170
	 Apparatus and method for rapid sealing of a flat panel display

	 7,804,236
	 11/378,105
	 Flat panel display incorporating control frame

	 7,786,663
	 11/724,793
	 Flat panel display having a control frame pedestal and method of making same

	 7,728,506
	 11/417,631
	 Low voltage phosphor with film electron emitters display device

	 7,723,908
	 11/484,889
	 Flat panel display incorporating a control frame

	 7,701,137
	 11/704,173
	 Apparatus for evacuating a field emission display

	 7,327,080
	 10/974,311
	 Hybrid active matrix thin-film transistor display

	 7,274,136
	 10/782,580
	 Hybrid active matrix thin-film transistor display

	 7,176,478
	 10/764,168
	 Nanotube-based vacuum devices

	 7,129,626
	 10/102,472
	 Pixel structure for an edge-emitter field-emission display

	 7,102,157
	 11/134,800
	 Nanotube-based vacuum devices

	 6,693,386
	 10/243,894
	 Reflective edge field-emission pixel and associated display

	 6,674,242
	 10/102,450
	 Field-emission matrix display based on electron reflections

	 6,614,149
	 10/102,467
	 Field-emission matrix display based on lateral electron reflections

	 6,590,320
	 09/511,437
	 Thin-film planar edge-emitter field emission flat panel display

	 NOA
	 12/288,402
	 Passive matrix phosphor based cold cathode display

	 

	 14/553,000
	 Passvie matrix phosphor based cold cathode display

	 

	 11/589,630
	 Pixel Structure for an Edge-Emitter Field-Emission Display

 

 

 

 

 
 APPENDIX C
 

 INTERNATIONAL CENTER FOR DISPUTE RESOLUTION INTERNATIONAL ARBITRATION TRIBUNAL
 

 

 

 In the Matter of the Arbitration between: 
 

 COPYTELE, INC., a Delaware Corporation
 

 

 Claimant,
 CASE NO.
 50-20-1300-0883
 

 

 and
 

 

 AU OPTRONICS CORPORATION, a Taiwanese Corporation,
 

 

 Respondent.
 

 

 NOTICE OF CLAIMANT’S VOLUNTARY WITHDRAWAL AND DISMISSAL WITH PREJUDICE OF ALL CLAIMS
 

 

 

 

 

 

 
 Claimant CopyTele, Inc. hereby provides notice to the Tribunal that Claimant desires to fully and finally resolve all claims in this Arbitration, and hereby voluntarily withdraws and dismisses with prejudice all claims against Respondent AU Optronics Corporation. Claimant has been authorized by Respondent to state that Respondent has no objections to this voluntary withdrawal and dismissal with prejudice, and that the parties have agreed that each party shall bear its own attorneys’ fees, expenses, and costs.
  
 Claimant respectfully requests that the Tribunal confirm, to the extent It deems necessary, that Claimant’s demand for arbitration and all claims contained in that demand, and any and all statements of claims made by Claimant, are hereby dismissed with prejudice in their entirety.
 

 

 Dated: December ___, 2014
 Respectfully submitted,
 

 

 

 LIEFF, CABRESER, HEIMANN & BERNSTEIN     LLP
 

           By:       ________________________________
 Richard M. Heimann
 Eric B. Fastiff
 David T. Rudolph
 Katherine L. Benson
 275 Battery Street, 29th Floor
 San Francisco, CA 94111-3339
 Telephone: (415) 956-1000
 Facsimile: (415) 956-1008
 

 Attorneys for Claimant CopyTele, Inc.
 

 

 

 

 
 APPENDIX D
 

 

 Eric B. Fastiff (State Bar No. 182260)
 efastiff@lchb.com
 David T. Rudolph (State Bar No. 233457)
 drudolph@lchb.com
 Katherine Lubin (State Bar No. 259826)
 klubin@lchb.com
 LIEFF CABRASER HEIMANN & BERNSTEIN, LLP
 275 Battery Street, 29th Floor
 San Francisco, California 94111-3339
 Telephone: (415) 956-1000
 Facsimile: (415) 956-1008
 

 Attorneys for Plaintiff CopyTele, Inc.
 

 UNITED STATES DISTRICT COURT
 

 NORTHERN DISTRICT OF CALIFORNIA
 

 

 

 

 

 COPYTELE, INC., a Delaware Corporation,
 

    
 Plaintiff,
 v.
 

 AU OPTRONICS CORPORATION, a Taiwanese corporation; E INK HOLDINGS, INC., a Taiwanese corporation; and E INK CORPORATION, a Delaware corporation,
 

 Defendants.
  
 Case No. 3:13-cv-00380-EMC
  
 STIPULATION AND [PROPOSED] ORDER OF DISMISSAL WITH PREJUDICE
  
 The Honorable Edward M. Chen
 
 
 WHEREAS, Plaintiff CopyTele, Inc. desires to voluntarily dismiss with prejudice any and all claims it has brought against any and all parties to this action;
 

 WHEREAS, Defendants AU Optronics Corporation, E Ink Holdings, Inc., and E Ink Corporation have no objection to the dismissal with prejudice of all of Plaintiff’s claims;
 

 WHEREAS, there are no counterclaims in this action that require resolution;
 

 

 

 

 
 WHEREAS, the parties agree to bear their own attorneys’ fees, expenses, and costs;
 

 NOW, THEREFORE, pursuant to Federal Rule of Civil Procedure 41(a)(1) and Civil Local Rule 7-12, IT IS HEREBY STIPULATED and AGREED by and between the parties through their designated counsel that this action in its entirety should be dismissed with prejudice, with each party to bear its own attorneys’ fees, expenses, and costs. The parties respectfully request that the Court enter an ORDER pursuant to this stipulation DISMISSING THIS ACTION WITH PREJUDICE.
 

 Dated: December __, 2014
 LIEFF, CABRASER, HEIMANN
 & BERNSTEIN, LLP
 By:_______________________________ 
  Eric B. Fastiff
 

 Eric B. Fastiff
 David T. Rudolph Katherine C. Lubin
 275 Battery Street, 29th Floor
 San Francisco, CA 94111-3339
 Telephone: (415) 956-1000
 Facsimile: (415) 956-1008
 efastiff@lchb.com drudolph@lchb.com klubin@lchb.com
 

 Attorneys for Plaintiff CopyTele, Inc.
 

 Dated: December __, 2014
 LATHAM & WATKINS LLP
 By: _______________________________
  Lawrence J. Gotts
 

 Lawrence J. Gotts
 555 Eleventh Street NW, Suite 1000
 Washington, DC 20004 Telephone: (202) 637-2200 Facsimile: (202) 637-2201 lawrence.gotts@lw.com
 

 

 

 

 
 Matthew Rawlinson
 140 Scott Drive
 Menlo Park, CA 94025 Telephone: (650) 328-4600 Facsimile: (650) 463-2600 matt.rawlinson@lw.com
 

 Attorneys for Defendant AU Optronics Corp.
 

 Dated: December __, 2014
 CROWELL & MORING LLP
 By: _____________________________ 
  Beatrice B. Nguyen
 

 Beatrice B. Nguyen
 275 Battery Street, Suite 2300 San Francisco, CA 94111 Telephone: (415) 986-2800 Facsimile: (415) 986.2827 bbnguyen@crowell.com
 

 Attorneys for Defendants E Ink Holdings, Inc. and E Ink Corporation
 

 

 

 [PROPOSED] ORDER
 

 

 PURSUANT TO STIPULATION, IT IS SO ORDERED.
 

 

 Dated: ______________________
 ___________________________
 The Honorable Edward M. Chen United States District Judge
 

 

 

 
 APPENDIX E
 

 ITUS Settles Lawsuit with AU Optronics
 

 MELVILLE, NY – January __, 2015: ITUS Corporation (“ITUS“) (OTCQB: ITUS), a company that builds and protects innovation, today announced that it has settled its lawsuit against AU Optronics Corporation (“AUO”). The settlement includes cash payments from AUO to ITUS totalling $9 million, the termination of AUO’s rights to ITUS’s patented Nano Field Emission Display (“nFED”) technology, and the transfer of ITUS’s electrophoretic display patent portfolio to AUO.
 

 Robert Berman, ITUS’s President and CEO stated, “This settlement accomplishes 2 very important goals for ITUS: it provides consideration for our EPD patents; and gives us the right to develop our nFED technology, which is now completely unencumbrered. The combination of our strong cash position, together with the significant potential from the patented technologies that we own or control, positions the company for continued growth in 2015 and beyond.”
 

 The settlement includes a $2 million payment pursuant to a Settlement Agreement, and $7 million payment pursuant to a Patent Assignment Agreement, and resolves a contact dispute between the parties emanating from two joint development and license agreements enterred into in May of 2011. A lawsuit filed by ITUS in January of 2012, and the ensuing arbitration which commenced on November 10, 2014, will be dismissed, with prejudice. Additional details of the settlement, in which neither party admits libility, are available on Form 8K filed today with the Securities and Exchange Commission.
 

 About ITUS Corporation
 ITUS develops and acquires patented technologies for the purposes of patent monetization and patent assertion. The company currently has 8 patent portfolios in the areas of Key Based Web Conferencing Encryption, Encrypted Cellular Communications, Nano Field Emission Display (“nFED”), Micro Electro Mechanical Systems Display (“MEMS”), J-Channel Window Frame Construction, VPN Multicast Communications, Internet Telephonic Gateway, and Enhanced Auction Technologies. Additional information is available at www.ITUScorp.com.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}]]